Fig. 1

Identification of serum metabolic profiles in SLE patients between the F1 group and the F2 group. (A) Unsupervised PCA model; (B) Supervised OPLS-DA model.

Identification of serum metabolic profiles in SLE patients between the F1 group and the F2 group. (A) Unsupervised PCA model; (B) Supervised OPLS-DA model.